Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. M...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf4a47d021b6457da642e660955cba02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bf4a47d021b6457da642e660955cba02 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bf4a47d021b6457da642e660955cba022021-11-25T17:03:00ZDiagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes10.3390/cancers132257122072-6694https://doaj.org/article/bf4a47d021b6457da642e660955cba022021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5712https://doaj.org/toc/2072-6694Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. Methods: We performed an exploratory, case-control study with 20 randomly selected MDS patients and nine controls with non-inflammatory (<i>n</i> = 3) and inflammatory conditions (<i>n</i> = 6). Patients were stratified in groups of lower (<i>n</i> = 10) and higher risk (<i>n</i> = 10) using IPSS-R. For the exploration of inflammasome and immune checkpoint activities, the expression of caspase-1 (Casp1), programmed cell death protein 1 (PD-1) and its ligand (PD-L1) were assessed in bone marrow samples using immunohistochemistry. Results: In multivariate analysis, we observed significant differences for Casp1 but not PD1/PD-L1 expression in our four conditions (<i>p</i> = 0.003). We found a discordant co-expression of Casp1/PD-L1 in MDS (rho = −0.41, <i>p</i> = 0.07) compared with a concordant co-expression in controls (rho = 0.64, <i>p</i> = 0.06). Neutrophil counts correlated directly with Casp1 (rho = 0.57, <i>p =</i> 0.009) but inversely with PD-L1 expression (rho = −0.58, <i>p</i> = 0.007). Conclusion: We identified characteristic discordant co-expression patterns in lower- (Casp1<sub>high</sub>/PD-L1<sub>low</sub>) and higher-risk MDS (Casp1<sub>low</sub>/PD-L1<sub>high</sub>), contrasting with concordant patterns in the non-inflammatory (Casp1<sub>low</sub>/PD-L1<sub>low</sub>) and inflammatory conditions (Casp1<sub>high</sub>/PD-L1<sub>high</sub>). Further validation is warranted in larger, prospective studies.Johannes R. GrafStefan ForsterFrido K. BruehlYara BanzMahmoud HallalJustine BrodardVera Ulrike BacherRamanjaneyulu AllamChristian M. SchürchNicolas BonadiesMDPI AGarticlemyelodysplastic syndromesinflammasomeimmune check-pointimmune-related biomarkersdiagnosisprognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5712, p 5712 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
myelodysplastic syndromes inflammasome immune check-point immune-related biomarkers diagnosis prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
myelodysplastic syndromes inflammasome immune check-point immune-related biomarkers diagnosis prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Johannes R. Graf Stefan Forster Frido K. Bruehl Yara Banz Mahmoud Hallal Justine Brodard Vera Ulrike Bacher Ramanjaneyulu Allam Christian M. Schürch Nicolas Bonadies Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
description |
Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. Methods: We performed an exploratory, case-control study with 20 randomly selected MDS patients and nine controls with non-inflammatory (<i>n</i> = 3) and inflammatory conditions (<i>n</i> = 6). Patients were stratified in groups of lower (<i>n</i> = 10) and higher risk (<i>n</i> = 10) using IPSS-R. For the exploration of inflammasome and immune checkpoint activities, the expression of caspase-1 (Casp1), programmed cell death protein 1 (PD-1) and its ligand (PD-L1) were assessed in bone marrow samples using immunohistochemistry. Results: In multivariate analysis, we observed significant differences for Casp1 but not PD1/PD-L1 expression in our four conditions (<i>p</i> = 0.003). We found a discordant co-expression of Casp1/PD-L1 in MDS (rho = −0.41, <i>p</i> = 0.07) compared with a concordant co-expression in controls (rho = 0.64, <i>p</i> = 0.06). Neutrophil counts correlated directly with Casp1 (rho = 0.57, <i>p =</i> 0.009) but inversely with PD-L1 expression (rho = −0.58, <i>p</i> = 0.007). Conclusion: We identified characteristic discordant co-expression patterns in lower- (Casp1<sub>high</sub>/PD-L1<sub>low</sub>) and higher-risk MDS (Casp1<sub>low</sub>/PD-L1<sub>high</sub>), contrasting with concordant patterns in the non-inflammatory (Casp1<sub>low</sub>/PD-L1<sub>low</sub>) and inflammatory conditions (Casp1<sub>high</sub>/PD-L1<sub>high</sub>). Further validation is warranted in larger, prospective studies. |
format |
article |
author |
Johannes R. Graf Stefan Forster Frido K. Bruehl Yara Banz Mahmoud Hallal Justine Brodard Vera Ulrike Bacher Ramanjaneyulu Allam Christian M. Schürch Nicolas Bonadies |
author_facet |
Johannes R. Graf Stefan Forster Frido K. Bruehl Yara Banz Mahmoud Hallal Justine Brodard Vera Ulrike Bacher Ramanjaneyulu Allam Christian M. Schürch Nicolas Bonadies |
author_sort |
Johannes R. Graf |
title |
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
title_short |
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
title_full |
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
title_fullStr |
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
title_full_unstemmed |
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes |
title_sort |
diagnostic and prognostic implications of caspase-1 and pd-l1 co-expression patterns in myelodysplastic syndromes |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/bf4a47d021b6457da642e660955cba02 |
work_keys_str_mv |
AT johannesrgraf diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT stefanforster diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT fridokbruehl diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT yarabanz diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT mahmoudhallal diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT justinebrodard diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT veraulrikebacher diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT ramanjaneyuluallam diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT christianmschurch diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes AT nicolasbonadies diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes |
_version_ |
1718412800036962304 |